caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821076753

Irena Charysz-BirskiM.D.

PRACTICENEUROLOGY CONSULTANTS PCSee all providers at this practice →
NeurologyDavenport, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Irena Charysz-Birski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 27 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
METROPOLITAN MEDICAL LABORATORY, PLC125350
GENESIS HEALTH SYSTEM86171
Christine Walsh
Diagnostic Radiology · Iowa City, IA
3769
ROGERS, JOHN3668
Edmund Coyne
Cardiology · Davenport, IA
2737
KETELAAR, MATTHEW2746
STATE UNIVERSITY OF IOWA2541
Mouhamed Al Sheikha
Nephrology · Davenport, IA
2448
Dietrich Gerhardt
Diagnostic Radiology · Davenport, IA
2246
TRINITY MEDICAL CENTER2244
Roopa Goswami
Diagnostic Radiology · Davenport, IA
2243
Rodney Short
Neurology · Davenport, IA
2135
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
911
Unique beneficiaries
—
Total services
19,524
Distinct HCPCS
20
Medicare payment
$161K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 103 Neurology providers in IA — top quintile (cohort median 518).
PRESCRIBING · PART D · 2024
Total Rx claims
1,987
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
50
Brand share
22.2%
Top prescribed drugs
Gabapentin324 claims
Lamotrigine174 claims
Levetiracetam128 claims
Carbidopa/Levodopa102 claims
Baclofen79 claims
QUALITY · MIPS · 2024
Final MIPS score
34.9
Quality
21.4
Cost
76.9
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-4.82%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$107
Payment records
5
By payment type
Food and Beverage$107